Appraisals - ASAR & FAR

13/05/2019

Final Recommendation: dolutegravir / rilpivirine (Juluca) 2850

30/11/2020

Final Recommendation: tiotropium (Spiriva Respimat) 1882

25/07/2019

Final Recommendation: fosaprepitant (Ivemend) 3789

25/07/2019

Final Recommendation: bictegravir (Biktarvy) 3414

25/07/2019

Final Recommendation: ipilimumab (Yervoy) 3604

25/07/2019

Final Recommendation: lanreotide (Somatuline Autogel) 1988

25/07/2019

Final Recommendation: octreotide (Sandostatin LAR) 3732

25/07/2019

Final Recommendation: levonorgestrel (Kyleena) 3582

12/05/2022

Final Recommendation: cariprazine (Reagila) 5032

12/05/2022

Final Recommendation: teriflunomide (Aubagio) 4033

12/05/2022

Final Recommendation: mercaptamine bitarate (Procysbi) 4804

16/03/2022

Final Recommendation: adalimumab (Humira) 4526

19/08/2019

Final Recommendation: tapentadol prolonged release (PalexiaSR) 651

23/02/2022

Final Recommendation: clostridium botulinum (Dysport) 2626

23/02/2022

Final Recommendation: inclisiran (Leqvio) 3746

23/02/2022

Final Recommendation: buprenorphine (Sixmo) 4262

23/02/2022

Final Recommendation: tirbanibulin (Klisyri) 4076

25/07/2019

Final Recommendation: dalbavancin (Xydalba) 2001

25/07/2019

Final Recommendation: selexipag (Uptravi) 700

25/07/2019

Final Recommendation: ranibizumab (Lucentis) 3233